The Centre for Medicinal Cannabis (CMC) are at the forefront of developing better medical cannabis policy for patient access in the UK, and believe this can only be facilitated through primary clinical research.
We have a unique capability to engage intelligently and strategically with all influential political and public policy stakeholders as well as relevant regulatory bodies, regulators to the medical and academic establishments, and producers of cannabis medicines.